PMID: 8981054Oct 1, 1996Paper

The dermorphin peptide family

General Pharmacology
P Melchiorri, L Negri

Abstract

1. In 1980, the skin of certain frogs belonging to the genus Phyllomedusinae was found to contain two new peptides that proved to be selective mu-opioid agonists. Given the name dermorphins, these were the first members of a peptide family that in the past 15 years has grown to reach a total of seven naturally occurring peptides and nearly 30 synthetic analogs. 2. Dermorphin peptides are potent analgesics in rodents and primates, including man. Some dermorphins can enter the blood-brain barrier and produce central antinociception after peripheral administration. 3. The dermorphin family also includes mu 1-opioid receptor selective agonists that produce intense opioid analgesia, but stimulate pulmonary ventilation. 4. Experiments in rats and mice chronically exposed to dermorphins have shown that not only do they have higher antinociceptive efficacy and potency than morphine, but they are also less likely than morphine to produce tolerance, dependence and opiate side effects.

References

Jan 1, 1992·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·V Erspamer
Mar 26, 1991·European Journal of Pharmacology·P MelchiorriD Barra
Jul 16, 1990·Biochemical and Biophysical Research Communications·A MorP Nicolas
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·K RichterG Kreil
Feb 1, 1989·Journal of the Autonomic Nervous System·C A MaggiA Meli
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·V ErspamerG Kreil
Jun 1, 1989·International Journal of Peptide and Protein Research·K M SivanandaiahV V Babu
Dec 1, 1989·Brain Research Bulletin·C M BarreraA J Kastin
Jan 1, 1989·Neuropeptides·A MorP Pradelles
Aug 15, 1985·Biochemical and Biophysical Research Communications·Y SasakiK Kisara
Jan 1, 1986·British Journal of Pharmacology·K KisaraH Watanabe
Oct 1, 1987·Pharmacological Research Communications·M Broccardo
May 1, 1987·Endocrinology·A GugliettaP Melchiorri
Apr 23, 1986·Brain Research·G SandriniR Pansini
Jan 1, 1985·Peptides·G Improta, A Guglietta
Jan 1, 1985·Peptides·N BassoM De Marco
Jan 1, 1986·Pharmacology, Biochemistry, and Behavior·N NakataK Suzuki
Feb 1, 1985·Neuropeptides·K TsouY Q Tang
Apr 1, 1985·Pharmacological Research Communications·M Broccardo
Mar 26, 1985·European Journal of Pharmacology·M BroccardoP Melchiorri
Sep 1, 1984·Neuroendocrinology·D GiudiciM Motta
Dec 1, 1984·Pharmacological Research Communications·L Negri, G Improta
May 1, 1983·The Journal of Clinical Endocrinology and Metabolism·E C Degli UbertiR Pansini
Mar 1, 1982·Regulatory Peptides·G ImprotaP Melchiorri
Jul 1, 1982·Regulatory Peptides·M BroccardoP Melchiorri

❮ Previous
Next ❯

Citations

Jan 2, 2001·Bioorganic & Medicinal Chemistry Letters·V SantagadaL H Lazarus
Jul 23, 2009·Journal of Medicinal Chemistry·Bhaswati SinhaJane V Aldrich
Mar 27, 2001·British Journal of Pharmacology·R MaldonadoL Negri
Jun 5, 2002·Chemical & Pharmaceutical Bulletin·Tadashi OgawaTadanori Morikawa
Mar 2, 2016·Journal of Peptide Science : an Official Publication of the European Peptide Society·Conan K WangDavid J Craik
Mar 31, 2016·Journal of Peptide Science : an Official Publication of the European Peptide Society·Oliwia FrączakAleksandra Olma
Oct 13, 2005·The Journal of Peptide Research : Official Journal of the American Peptide Society·S BalletD Tourwé
Nov 8, 2014·Journal of Veterinary Pharmacology and Therapeutics·M A RobinsonL R Soma
Mar 29, 2014·British Journal of Pharmacology·T A MaceyS L Ingram
Apr 14, 2016·Journal of the American Chemical Society·Liujie Huo, Wilfred A van der Donk
Oct 12, 2010·Toxicon : Official Journal of the International Society on Toxinology·Breno RatesAdriano M C Pimenta
Mar 20, 1999·General and Comparative Endocrinology·P B Danielson, R M Dores
Jul 23, 2016·Journal of Peptide Science : an Official Publication of the European Peptide Society·Maciej MaciejczykAleksandra Olma
Oct 4, 2016·Journal of Medicinal Chemistry·Olivier Van der PoortenDirk Tourwé
Nov 20, 2012·Toxicon : Official Journal of the International Society on Toxinology·M NeivaM A F Hayashi
Nov 5, 2016·Molecular Biology of the Cell·Raphael JorandTijana Jovanovic-Talisman
Sep 11, 2007·Bioorganic & Medicinal Chemistry Letters·Kimitaka ShiotaniYoshio Okada
Dec 21, 2006·Journal of Peptide Science : an Official Publication of the European Peptide Society·Laura BiondiRaniero Rocchi
Sep 5, 2006·Bioorganic & Medicinal Chemistry Letters·Kimitaka ShiotaniYoshio Okada
Nov 19, 2003·Journal of Peptide Science : an Official Publication of the European Peptide Society·Laura BiondiRaniero Rocchi
Jun 22, 2010·Chemistry & Biodiversity·Sergio Martínez-RodríguezFrancisco Javier Las Heras-Vázquez
May 27, 2003·Biopolymers·Sharon D BryantLawrence H Lazarus
Jan 14, 2021·Drug Testing and Analysis·Fernando MoreiraMaria de Lourdes Bastos
Mar 18, 1999·Progress in Neurobiology·L H LazarusS Salvadori
Dec 3, 2002·Journal of Medicinal Chemistry·Gianfranco BalboniLawrence H Lazarus
Jul 11, 2003·Journal of Medicinal Chemistry·Yoshio OkadaLawrence H Lazarus
Sep 24, 2020·Current Topics in Medicinal Chemistry·Hirokazu Mizoguchi, Hideaki Fujii
Nov 21, 2017·ACS Medicinal Chemistry Letters·Olivier Van der PoortenSteven Ballet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.